28th April 2020: Northwell Health CEO Michael Dowling said that scientists working on
a drug trial for Famotidine, a common heartburn medication, have “a reasonable conﬁdence” that the drug may make a difference in the treatment of Covid-19 patients.
30th April 2020: After Gilead Science’s anti-viral drug remdesivir showed signs that it could become a standard of care to ﬁght Covid-19 pandemic, a US government disease expert welcomed the key clinical trial results. India, too, may pin its hopes on the drug in a bid to treat rising Covid-19 patients.
29th April 2020: Indian vaccine makers were part of a WHO-organised virtual meeting of manufacturers and national regulators from the South-East Asia region, seen by the UN body as having “the quality and scale required to produce and roll-out a Covid-19 vaccine globally”.